| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Financial Officer
1 company
Parison Amy is a SVP, Chief Financial Officer at Editas Medicine, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $48K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | EDIT Editas Medicine, Inc. | SVP, Chief Financial Officer | Sell | 461 | $2.15 | $992.58 | -2.8% | -13.7% | - | |
| Sep 3, 2025 | EDIT Editas Medicine, Inc. | SVP, Chief Financial Officer | Sell | 458 | $2.60 | $1,189.01 | -2.7% | -15.6% | - | |
| Aug 7, 2025 | EDIT Editas Medicine, Inc. | SVP, Chief Financial Officer | Sell | 679 | $2.58 | $1,751.82 | -3.9% | +11.6% | - | |
| Jun 3, 2025 | EDIT Editas Medicine, Inc. | SVP, Chief Financial Officer | Sell | 446 | $1.72 | $768.90 | -2.5% | +35.7% | - |